Subscribe to RSS

DOI: 10.1055/s-0045-1812295
The Potential of Hypofractionated Radiotherapy: A Revolutionary Treatment for Anorectal Malignant Melanomas
Authors
Abstract
Mucosal melanomas generally arise from mucosal epithelium lining the respiratory, alimentary, and genitourinary tracts and usually carry worse prognosis than cutaneous melanomas. Anorectal melanomas account for 50% of gastrointestinal tract melanomas and 0.3 to 1% of all malignant melanomas. There are no specific treatment guidelines due to the scarcity of the disease, its unique biology, and challenges in management owing to the anatomic location. We report a case of anorectal malignant melanoma treated successfully with abdominoperineal resection followed by hypofractionated radiotherapy in a setting where financial toxicity limits treatment options. The patient presents complete response 2 years postdiagnosis, emphasizing that radiation therapy can be utilized for more than just palliation.
Authors' Contributions
VT: data collection, data curation, data analysis and interpretation, writing – original draft, accountability for all aspects of the work; PP: provision of study material and patient care; HS: writing – original draft, critical review and editing of the manuscript; AT: writing – review & editing; AJ: conception and design; PV: final approval of the manuscript.
Informed Consent
Informed consent was obtained from all patients included in the study.
Publication History
Received: 19 March 2025
Accepted: 25 July 2025
Article published online:
27 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Vandana Thakur, Poorva Vias, Hardik Sharma, Pratibha Prashar, Aditya Jamwal, Anupam Thakur. The Potential of Hypofractionated Radiotherapy: A Revolutionary Treatment for Anorectal Malignant Melanomas. Brazilian Journal of Oncology 2025; 21: s00451812295.
DOI: 10.1055/s-0045-1812295
-
References
- 1 Chang AE, Karnell LH, Menck HR. The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998; 83 (08) 1664-1678 . Doi: 10.1002/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g
- 2 Paolino G, Didona D, Macrì G, Calvieri S, Mercuri SR. Anorectal Melanoma. In: Scott JF, Gerstenblith MR. editors. Noncutaneous Melanoma. Brisbane: Codon Publications; 2018: 83-98 Available from: https://www.ncbi.nlm.nih.gov/books/NBK506988/
- 3 Menon H, Patel RR, Cushman TR, Amini A, Seyedin SN, Adams AC. et al. Management and outcomes of primary anorectal melanoma in the United States. Future Oncol 2020; 16 (08) 329-338
- 4 Pandey M, Mathew A, Abraham EK, Ahamed IM, Nair KM. Primary malignant melanoma of the mucous membranes. Eur J Surg Oncol 1998; 24 (04) 303-307
- 5 Sutherland CM, Chmiel JS, Henson DE, Cunningham MP, Peace BB, Winchester DP. Patient characteristics, methods of diagnosis and treatment of melanoma in the United States. Surg Gynecol Obstet 1992; 175 (02) 129-134
- 6 Tanaka S, Ohta T, Fujimoto T, Makino Y, Murakami I. Endoscopic mucosal resection of primary anorectal malignant melanoma: a case report. Acta Med Okayama 2008; 62 (06) 421-424
- 7 Slingluff Jr CL, Vollmer RT, Seigler HF. Anorectal melanoma: clinical characteristics and results of surgical management in twenty-four patients. Surgery 1990; 107 (01) 1-9
- 8 Konstadoulakis MM, Ricaniadis N, Walsh D, Karakousis CP. Malignant melanoma of the anorectal region. J Surg Oncol 1995; 58 (02) 118-120
- 9 Roumen RMH. Anorectal melanoma in The Netherlands: a report of 63 patients. Eur J Surg Oncol 1996; 22 (06) 598-601
- 10 Thibault C, Sagar P, Nivatvongs S, Ilstrup DM, Wolff BG. Anorectal melanoma–an incurable disease?. Dis Colon Rectum 1997; 40 (06) 661-668
- 11 Bentzen SM, Overgaard J, Thames HD, Overgaard M, Hansen PV, von der Maase H, Meder J. Clinical radiobiology of malignant melanoma. Radiother Oncol 1989; 16 (03) 169-182
- 12 Harwood AR, Cummings BJ. Radiotherapy for mucosal melanomas. Int J Radiat Oncol Biol Phys 1982; 8 (07) 1121-1126
- 13 Ang KK, Byers RM, Peters LJ, Maor MH, Wendt CD, Morrison WH. et al. Regional radiotherapy as adjuvant treatment for head and neck melanoma. Arch Otolaryngol Head Neck Surg 1990; 116: 169-172
- 14 Balch CM, Reintgen DS, Kirkwood JM, Houghton A. Cutaneous melanoma. In: DeVita VT, Hellman S, Rosenberg SA. editors. Devita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 5th ed. Vol. 2.. New York: Lippincott-Raven Publishers; 1997: 1975
- 15 Keatts SA, Salem AF, Swanson DM, Farooqi A, Bishop AJ, Amaria RN. et al. Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma. Clin Transl Radiat Oncol 2024; 49: 100856